Literature DB >> 27132574

Assays of Serum Testosterone.

Amin S Herati1, Cenk Cengiz1, Dolores J Lamb2.   

Abstract

The diagnosis of male hypogonadism depends on an assessment of the clinical signs and symptoms of hypogonadism and serum testosterone level. Current clinical laboratory testosterone assay platforms include immunoassays and mass spectrometry. Despite significant advances to improve the accuracy and precision of the currently available assays, limited comparability exists between assays at the lower and upper extremes of the testosterone range. Because of this lack of comparability, there is no current gold standard assay for the assessment of total testosterone levels.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adult; Circadian rhythm; Humans; Hypogonadism/metabolism; Immunoassay; Steroids/blood; Testosterone/blood; Testosterone/deficiency

Mesh:

Substances:

Year:  2016        PMID: 27132574     DOI: 10.1016/j.ucl.2016.01.003

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  5 in total

1.  Simultaneous measurement of total estradiol and testosterone in human serum by isotope dilution liquid chromatography tandem mass spectrometry.

Authors:  Hui Zhou; Yuesong Wang; Matthew Gatcombe; Jacob Farris; Julianne C Botelho; Samuel P Caudill; Hubert W Vesper
Journal:  Anal Bioanal Chem       Date:  2017-08-11       Impact factor: 4.142

Review 2.  Testosterone monitoring for men with advanced prostate cancer: Review of current practices and a survey of Canadian physicians.

Authors:  Bobby Shayegan; Frédéric Pouliot; Alan So; John Fernandes; Joseph Macri
Journal:  Can Urol Assoc J       Date:  2017-06       Impact factor: 1.862

Review 3.  Testosterone and the Heart.

Authors:  Travis Goodale; Archana Sadhu; Steven Petak; Richard Robbins
Journal:  Methodist Debakey Cardiovasc J       Date:  2017 Apr-Jun

4.  A New LC-MS/MS Method for Simultaneous and Quantitative Detection of Bisphenol-A and Steroids in Target Tissues: A Power Tool to Characterize the Interference of Bisphenol-A Exposure on Steroid Levels.

Authors:  Sonia Errico; Teresa Chioccarelli; Martina Moggio; Nadia Diano; Gilda Cobellis
Journal:  Molecules       Date:  2019-12-21       Impact factor: 4.411

5.  Elevated testosterone on immunoassay in a patient with metastatic prostate cancer following androgen deprivation therapy and bilateral orchiectomy.

Authors:  Arjun Sarkar; Mohammad Rashid Siddiqui; Richard J Fantus; Maha Hussain; Joshua A Halpern; Ashley E Ross
Journal:  Urol Case Rep       Date:  2021-03-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.